GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Astec Lifesciences Ltd

Astec Lifesciences Board Meeting Scheduled 27 April 2026 for FY26 Results

RESULTS ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 17 Apr 2026, 10:06 PM IST  ·  BSE ID: ec8b58f7-77d4-4227-807c-aba5b931358e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has scheduled a board meeting on 27 April to officially approve and release its year-end financial results for the 12 months ending March 2026.
🤖 AI Summary
  • Board meeting scheduled 27 April 2026 to approve FY26 audited financial results
  • Covers standalone and consolidated results for quarter and full year ended 31 March 2026
  • Meeting follows Audit Committee review as per SEBI Listing Regulations Regulation 29
  • No financial data disclosed in this intimation — results approval pending Board meeting
👥 What This Means For Shareholders
✅
Action Required
Mark 27 April 2026 for results announcement. No shareholder action required before this date.
👤
Who Is Affected
All shareholders. FY26 results will impact equity valuation, dividend prospects, and earnings per share assessments.
🔍
Management Signal
Routine board governance — company is on track to release audited results within standard timeline.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
FY26 audited financial results release on or after 27 April 2026 — check revenue and profit
Audit Committee review completion before 27 April meeting — watch for audit qualifications
Dividend announcement if declared — monitor for payout ratio and cash position
LOW RISK Routine results approval filing. No material risks identified. Standard governance disclosure under SEBI regulations.
💡 Investor Takeaway
Board meeting confirmed for 27 April 2026 to approve FY26 audited financial results for standalone and consolidated statements. No financial metrics disclosed in this intimation. Actual performance data will follow Board approval.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.